EUVIMEDEUVIMED entdecken
Crossref

Evaluation of [ 18 F]RoSMA-18-d 6 as a CB2 PET Radioligand in Nonhuman Primates

Achi Haider iD, Lu Wang iD, Luca Gobbi iD, Yinlong Li, Ahmad Chaudhary, Xin Zhou, Jiahui Chen iD, Chunyu Zhao, Jian Rong iD, Zhiwei Xiao, Lu Hou, Nehal H Elghazawy und 10 weitere

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Achi Haider und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Stree…. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Positron-Emission Tomography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsPositron-Emission TomographyAnimalsHumansLigandsBrainPrimatesReceptor, Cannabinoid, CB2Fluorine RadioisotopesMammals

Stichwörter der Autor:innen

cannabinoid type 2 receptorinflammationpositron emission tomographytracer developmenttranslational molecular imaging

Substanzen

RadiopharmaceuticalsLigandsReceptor, Cannabinoid, CB2Fluorine Radioisotopes

Autor:innen und Institutionen

  • Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States.
  • Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
  • Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, 4070 Basel, Switzerland.
  • Institute of Pharmacy, Department of Medicinal Chemistry, Martin-Luther-University Halle-Wittenberg, W.-Langenbeck-Str. 4, 06120 Halle, Germany.
  • Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston Salem, North Carolina 27157, United States.

ORCID-Profile: Achi Haider, Lu Wang, Luca Gobbi, Jiahui Chen, Jian Rong, Wolfgang Sippl, Hazem Ahmed, Steven H Liang, Simon M Ametamey

Förderung

  • Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Zitieren

APA

Haider, A., Wang, L., Gobbi, L., Li, Y., Chaudhary, A., Zhou, X., Chen, J., Zhao, C., Rong, J., Xiao, Z., Hou, L., Elghazawy, N. H., Sippl, W., Davenport, A. T., Daunais, J. B., Ahmed, H., Crowe, R., Honer, M., Rominger, A., …, & Ametamey, S. M. (2023). Evaluation of [ 18 F]RoSMA-18-d 6 as a CB2 PET Radioligand in Nonhuman Primates. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00222

Vancouver

Haider A, Wang L, Gobbi L, Li Y, Chaudhary A, Zhou X, et al. Evaluation of [ 18 F]RoSMA-18-d 6 as a CB2 PET Radioligand in Nonhuman Primates. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00222

BibTeX
@article{Haider2023,
  author = {Haider, Achi and Wang, Lu and Gobbi, Luca and Li, Yinlong and Chaudhary, Ahmad and Zhou, Xin and Chen, Jiahui and Zhao, Chunyu and Rong, Jian and Xiao, Zhiwei and Hou, Lu and Elghazawy, Nehal H and Sippl, Wolfgang and Davenport, April T and Daunais, James B and Ahmed, Hazem and Crowe, Ron and Honer, Michael and Rominger, Axel and Grether, Uwe and Liang, Steven H and Ametamey, Simon M},
  title = {Evaluation of [ 18 F]RoSMA-18-d 6 as a CB2 PET Radioligand in Nonhuman Primates},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00222}
}
Kostenlos starten →